Therapeutic Drug Monitoring of Cyclosporine Neoral in de Novo Chinese Cardiac Transplant Recipients Treated with an Everolimus-Cyclosporine Immunosuppressive Regimen

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2132-2134

  Wang, C H ^a   Chou, N K ^a   Wu, F L L ^b   Ko, W J ^a   Tsao, C I ^a   Chi, N H ^a   Hsu, R B ^a   Wang, S S ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; EVEROLIMUS; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CARDIAC GRAFT REJECTION; CHINESE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG BIOAVAILABILITY; DRUG MONITORING; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LINEAR REGRESSION ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADULT; AREA UNDER CURVE; CYCLOSPORINE; DRUG MONITORING; DRUG THERAPY, COMBINATION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; SIROLIMUS; TAIWAN;

EID: 33846066741     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.050     Document Type: Article

References (9)

1. Eisen H.J., Tuzcu M.T., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847
2. Chien N.C., Lin F.L., and Chou N.K. Rabbit antithymocyte globulin induction immunosuppression in heart transplantation. Transplant Proc 32 (2000) 2380
3. Kirchner G.I., Meier-Wiedenbach I., and Manns M.P. Clinical pharmacokinetics of everolimus. Clin Pharmacokinet 43 (2004) 83
4. Kirchner G.I., Winkler M., Mueller L., et al. Pharmacokinetics of SDZ RAD and cyclosporine including their metabolites in seven kidney graft patients after the first dose of SDZ RAD. Br J Clin Pharmacol 50 (2000) 449
5. Kirchner G., Mueller L., Winkler M., et al. Long-term pharmacokinetics of the metabolites of everolimus and cyclosporine in renal transplant recipients. Transplant Proc 34 (2002) 2233
6. Johnston A., David O.J., and Cooney G.F. Pharmacokinetic validation of Neoral absorption profile. Transplant Proc 32 (2000) 53S
7. Wang C.H., Ko W.J., Chou N.K., et al. A limited sampling strategy for the estimation of 12-hour cyclosporine Neoral area under the curve in Chinese cardiac transplant recipients. Transplant Proc 36 (2004) 2390
8. Cantarovich M., Elstein E., Varennes B., et al. Clinical benefit of Neoral dose monitoring with cyclosoprine 2-hour post-dose levels compared with trough levels in stable heart transplant patients. Transplantation 68 (1999) 1839
9. Delgado D.H., and Ross H.J. The promise of C2, simulect, and Certican in heart transplantation. Transplant Proc 36 (2004) 504S